BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 24954893)

  • 1. Interleukin-2-mediated inhibition of dendritic cell development correlates with decreased CD135 expression and increased monocyte/macrophage precursors.
    Guerrero AD; Dong MB; Zhao Y; Lau-Kilby A; Tarbell KV
    Immunology; 2014 Dec; 143(4):640-50. PubMed ID: 24954893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-2 inhibits FMS-like tyrosine kinase 3 receptor ligand (flt3L)-dependent development and function of conventional and plasmacytoid dendritic cells.
    Lau-Kilby AW; Kretz CC; Pechhold S; Price JD; Dorta S; Ramos H; Trinchieri G; Tarbell KV
    Proc Natl Acad Sci U S A; 2011 Feb; 108(6):2408-13. PubMed ID: 21262836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The concerted action of GM-CSF and Flt3-ligand on in vivo dendritic cell homeostasis.
    Kingston D; Schmid MA; Onai N; Obata-Onai A; Baumjohann D; Manz MG
    Blood; 2009 Jul; 114(4):835-43. PubMed ID: 19465690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive and controlled development of mouse dendritic cells from Flt3+CD11b+ progenitors in vitro.
    Hieronymus T; Gust TC; Kirsch RD; Jorgas T; Blendinger G; Goncharenko M; Supplitt K; Rose-John S; Müller AM; Zenke M
    J Immunol; 2005 Mar; 174(5):2552-62. PubMed ID: 15728461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutting edge: generation of splenic CD8+ and CD8- dendritic cell equivalents in Fms-like tyrosine kinase 3 ligand bone marrow cultures.
    Naik SH; Proietto AI; Wilson NS; Dakic A; Schnorrer P; Fuchsberger M; Lahoud MH; O'Keeffe M; Shao QX; Chen WF; Villadangos JA; Shortman K; Wu L
    J Immunol; 2005 Jun; 174(11):6592-7. PubMed ID: 15905497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic control of dendritic cell development and fate determination of common myeloid progenitor by Mysm1.
    Won H; Nandakumar V; Yates P; Sanchez S; Jones L; Huang XF; Chen SY
    Blood; 2014 Oct; 124(17):2647-56. PubMed ID: 25217698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered compensatory cytokine signaling underlies the discrepancy between
    Durai V; Bagadia P; Briseño CG; Theisen DJ; Iwata A; Davidson JT; Gargaro M; Fremont DH; Murphy TL; Murphy KM
    J Exp Med; 2018 May; 215(5):1417-1435. PubMed ID: 29572360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bcl11a controls Flt3 expression in early hematopoietic progenitors and is required for pDC development in vivo.
    Wu X; Satpathy AT; Kc W; Liu P; Murphy TL; Murphy KM
    PLoS One; 2013; 8(5):e64800. PubMed ID: 23741395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PU.1 is essential for CD11c expression in CD8(+)/CD8(-) lymphoid and monocyte-derived dendritic cells during GM-CSF or FLT3L-induced differentiation.
    Zhu XJ; Yang ZF; Chen Y; Wang J; Rosmarin AG
    PLoS One; 2012; 7(12):e52141. PubMed ID: 23284905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the Flt3 signal transduction cascade rescues and enhances type I interferon-producing and dendritic cell development.
    Onai N; Obata-Onai A; Tussiwand R; Lanzavecchia A; Manz MG
    J Exp Med; 2006 Jan; 203(1):227-38. PubMed ID: 16418395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flt3 ligand regulates dendritic cell development from Flt3+ lymphoid and myeloid-committed progenitors to Flt3+ dendritic cells in vivo.
    Karsunky H; Merad M; Cozzio A; Weissman IL; Manz MG
    J Exp Med; 2003 Jul; 198(2):305-13. PubMed ID: 12874263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Porcine Flt3 ligand and its receptor: generation of dendritic cells and identification of a new marker for porcine dendritic cells.
    Guzylack-Piriou L; Alves MP; McCullough KC; Summerfield A
    Dev Comp Immunol; 2010 Apr; 34(4):455-64. PubMed ID: 20015454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of murine dendritic cells from flt3-ligand-supplemented bone marrow cultures.
    Brasel K; De Smedt T; Smith JL; Maliszewski CR
    Blood; 2000 Nov; 96(9):3029-39. PubMed ID: 11049981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of natural type I IFN-producing and dendritic cell development by a small molecule receptor tyrosine kinase inhibitor with Flt3 affinity.
    Tussiwand R; Onai N; Mazzucchelli L; Manz MG
    J Immunol; 2005 Sep; 175(6):3674-80. PubMed ID: 16148112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo analysis of dendritic cell development and homeostasis.
    Liu K; Victora GD; Schwickert TA; Guermonprez P; Meredith MM; Yao K; Chu FF; Randolph GJ; Rudensky AY; Nussenzweig M
    Science; 2009 Apr; 324(5925):392-7. PubMed ID: 19286519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow precursors of nonobese diabetic mice develop into defective macrophage-like dendritic cells in vitro.
    Nikolic T; Bunk M; Drexhage HA; Leenen PJ
    J Immunol; 2004 Oct; 173(7):4342-51. PubMed ID: 15383563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cell development requires histone deacetylase activity.
    Chauvistré H; Küstermann C; Rehage N; Klisch T; Mitzka S; Felker P; Rose-John S; Zenke M; Seré KM
    Eur J Immunol; 2014 Aug; 44(8):2478-88. PubMed ID: 24810486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined TLR stimulation with Pam3Cys and Poly I: C enhances Flt3-ligand dendritic cell activation for tumor immunotherapy.
    Lim SN; Kuhn S; Hyde E; Ronchese F
    J Immunother; 2012; 35(9):670-9. PubMed ID: 23090076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergy between rapamycin and FLT3 ligand enhances plasmacytoid dendritic cell-dependent induction of CD4+CD25+FoxP3+ Treg.
    Biswas M; Sarkar D; Kumar SR; Nayak S; Rogers GL; Markusic DM; Liao G; Terhorst C; Herzog RW
    Blood; 2015 May; 125(19):2937-47. PubMed ID: 25833958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory Dendritic Cells Induced by Bendamustine Are Associated With Enhanced Flt3 Expression and Alloreactive T-Cell Death.
    Molina MS; Hoffman EA; Stokes J; Kummet N; Smith KA; Baker F; Zúñiga TM; Simpson RJ; Katsanis E
    Front Immunol; 2021; 12():699128. PubMed ID: 34249005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.